Allogeneic transplant for peripheral T-cell lymphoma: a sparkle of hope and many questions.

about

Allogeneic transplant for peripheral T-cell lymphoma: a sparkle of hope and many questions.

Item

http://www.wikidata.org/entity/Q47586189

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Allogeneic transplant for peri ...... le of hope and many questions.

@en

Allogeneic transplant for peri ...... le of hope and many questions.

@nl

type

Item

label

Allogeneic transplant for peri ...... le of hope and many questions.

@en

Allogeneic transplant for peri ...... le of hope and many questions.

@nl

prefLabel

Allogeneic transplant for peri ...... le of hope and many questions.

@en

Allogeneic transplant for peri ...... le of hope and many questions.

@nl

P1476

Allogeneic transplant for peri ...... le of hope and many questions.

@en

P2093

Erika Ramsdale

http://www.w3.org/2001/XMLSchema#string

P2860

Frailty in older adults: evidence for a phenotype

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte

The application of the principles of geriatrics to the management of the older person with cancer.

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).

EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer.

Diffuse large B-cell lymphoma in the elderly: diffusion of treatment with rituximab and survival advances with and without anthracyclines

Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma.

Treatment of elderly patients with intermediate- and high-grade non-Hodgkin's lymphoma: a retrospective population-based study.

Incidence of neutropenia, chemotherapy delivery, and use of colony-stimulating factor in patients with non-Hodgkin lymphoma of different age groups.

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.

P304

1415-1417

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2011.582657

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Koen van Besien

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51153266

http://www.w3.org/2001/XMLSchema#string

P698

21599586

http://www.w3.org/2001/XMLSchema#string